Corgenix signs deal to develop diagnostic product for Eli Lilly

BROOMFIELD — Corgenix Medical Corp. (OTC BB: CONX.OB) in Broomfield, a maker of diagnostic kits for the medical industry, has entered an agreement to develop diagnostic kits for Indiana-based Eli Lilly and Co. (NYSE: LLY), according to documents filed Aug. 19 with the Securities and Exchange Commission.

Financial terms of the agreement, signed Aug. 15, were not disclosed.

The agreement covers technology transfer, licensing and product development on diagnostic kits for Eli Lilly. What the kits would be used for was not disclosed.

The two companies first will work together to study the feasibility of developing and manufacturing certain diagnostic test kits for…